ReP USP - Resultado da busca

Artigo de periodico
Cross-sectional analysis reveals autoantibody signatures associated with COVID-19 severity (2023)
Baiocchi, Gabriela Crispim ; Vojdani, Aristo ; Rosenberg, Avi Z. ; Vojdani, Elroy ; Halpert, Gilad ; Yuri Ostrinski ; Israel Zyskind ; Filgueiras, Igor Salerno ; Schimke, Lena Friederike ; Marques, Alexandre Henrique Carvalho ; Giil, Lasse M. ; Lavi, Yael Bublil ; Silverberg, Jonathan I. ; Zimmerman, Jason; Hill, Dana Ashley ; Thornton, Amanda ; Kim, Myungjin; Vito, Roberta De ; Fonseca, Dennyson Leandro Mathias da ; Plaça, Desireé Rodrigues ; Freire, Paula Paccielli ; Carmen Scheibenbogen ; Heidecke, Harald; Lattin, Miriam T.; Ochs, Hans D. ; Gabriela Riemekasten ; Howard Amital ; Yehuda Shoenfeld ; Câmara, Niels Olsen Saraiva ; Calich, Vera Lúcia Garcia ; Marques, Otavio Cabral
Source: Journal of Medical Virology. Unidades: ICB, FCF
Subjects: IMUNOLOGIA, COVID-19, INFECÇÕES POR CORONAVIRUS, INFECÇÕES POR VÍRUS DE RNA, DOENÇAS AUTOIMUNES, AUTOANTICORPOS, IMUNOPROTEÍNAS, CITOCINAS, QUIMIOCINAS, IMUNOGLOBULINAS, ESTUDOS TRANSVERSAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BAIOCCHI, Gabriela Crispim et al. Cross-sectional analysis reveals autoantibody signatures associated with COVID-19 severity. Journal of Medical Virology, v. 95, n. 1, p. 1-13, 2023Tradução . . Disponível em: https://doi.org/10.1002/jmv.28538. Acesso em: 15 nov. 2024.
APA
Baiocchi, G. C., Vojdani, A., Rosenberg, A. Z., Vojdani, E., Halpert, G., Yuri Ostrinski,, et al. (2023). Cross-sectional analysis reveals autoantibody signatures associated with COVID-19 severity. Journal of Medical Virology, 95( 1), 1-13. doi:10.1002/jmv.28538
NLM
Baiocchi GC, Vojdani A, Rosenberg AZ, Vojdani E, Halpert G, Yuri Ostrinski, Israel Zyskind, Filgueiras IS, Schimke LF, Marques AHC, Giil LM, Lavi YB, Silverberg JI, Zimmerman J, Hill DA, Thornton A, Kim M, Vito RD, Fonseca DLM da, Plaça DR, Freire PP, Carmen Scheibenbogen, Heidecke H, Lattin MT, Ochs HD, Gabriela Riemekasten, Howard Amital, Yehuda Shoenfeld, Câmara NOS, Calich VLG, Marques OC. Cross-sectional analysis reveals autoantibody signatures associated with COVID-19 severity [Internet]. Journal of Medical Virology. 2023 ; 95( 1): 1-13.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1002/jmv.28538
Vancouver
Baiocchi GC, Vojdani A, Rosenberg AZ, Vojdani E, Halpert G, Yuri Ostrinski, Israel Zyskind, Filgueiras IS, Schimke LF, Marques AHC, Giil LM, Lavi YB, Silverberg JI, Zimmerman J, Hill DA, Thornton A, Kim M, Vito RD, Fonseca DLM da, Plaça DR, Freire PP, Carmen Scheibenbogen, Heidecke H, Lattin MT, Ochs HD, Gabriela Riemekasten, Howard Amital, Yehuda Shoenfeld, Câmara NOS, Calich VLG, Marques OC. Cross-sectional analysis reveals autoantibody signatures associated with COVID-19 severity [Internet]. Journal of Medical Virology. 2023 ; 95( 1): 1-13.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1002/jmv.28538
Artigo de periodico-carta/editorial
Harnessing Type I IFN immunity against SARS-CoV-2 with early administration of IFN-β (2021)
Vinh, Donald C. ; Abel, Laurent ; Bastard, Paul ; Cheng, Matthew P. ; Condino Neto, Antonio ; Gregersen, Peter K. ; Haerynck, Filomeen ; Cicalese, Maria-Pia ; Hagin, David; Palacín, Pere Soler ; Planas, Anna M. ; Pujol, Aurora ; Notarangelo, Luigi D. ; Zhang, Qian ; Su, Helen C. ; Casanova, Jean-Laurent ; Meyts, Isabelle
Source: Journal of Clinical Immunology. Unidade: ICB
Subjects: IMUNOLOGIA, IMUNIDADE, IMUNODEFICIÊNCIA DE VARIÁVEL COMUM, IMUNOGENÉTICA, COVID-19, INTERFERON TIPO I, INFECÇÕES POR CORONAVIRUS, ESTUDOS DE COORTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VINH, Donald C. et al. Harnessing Type I IFN immunity against SARS-CoV-2 with early administration of IFN-β. Journal of Clinical Immunology. New York: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1007/s10875-021-01068-6. Acesso em: 15 nov. 2024. , 2021
APA
Vinh, D. C., Abel, L., Bastard, P., Cheng, M. P., Condino Neto, A., Gregersen, P. K., et al. (2021). Harnessing Type I IFN immunity against SARS-CoV-2 with early administration of IFN-β. Journal of Clinical Immunology. New York: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1007/s10875-021-01068-6
NLM
Vinh DC, Abel L, Bastard P, Cheng MP, Condino Neto A, Gregersen PK, Haerynck F, Cicalese M-P, Hagin D, Palacín PS, Planas AM, Pujol A, Notarangelo LD, Zhang Q, Su HC, Casanova J-L, Meyts I. Harnessing Type I IFN immunity against SARS-CoV-2 with early administration of IFN-β [Internet]. Journal of Clinical Immunology. 2021 ; 1-18.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1007/s10875-021-01068-6
Vancouver
Vinh DC, Abel L, Bastard P, Cheng MP, Condino Neto A, Gregersen PK, Haerynck F, Cicalese M-P, Hagin D, Palacín PS, Planas AM, Pujol A, Notarangelo LD, Zhang Q, Su HC, Casanova J-L, Meyts I. Harnessing Type I IFN immunity against SARS-CoV-2 with early administration of IFN-β [Internet]. Journal of Clinical Immunology. 2021 ; 1-18.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1007/s10875-021-01068-6
Artigo de periodico
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths (2021)
Bastard, Paul ; Gervais, Adrian ; Voyer, Tom Le ; Rosain, Jérémie ; Philippot, Quentin; Manry, Jérémy ; Michailidis, Eleftherios ; Hoffmann, Hans-Heinrich ; Eto, Shohei; Garcia-Prat, Marina; Bizien, Lucy; Parra-Martínez, Alba; Yang, Rui; Liis, Haljasmägi; Migaud, Mélanie; Särekannu, Karita; Maslovskaja, Julia; Prost, Nicolas de; Tandjaoui-Lambiotte, Yacine; Luyt , Charles-Edouard; Amador-Borrero, Blanca; Alexandre, Gaudet; Poissy, Julien; Morel, Pascal; Richard, Pascale; Cognasse, Fabrice; Troya, Jesus; Trouillet-Assant, Sophie; Belot, Alexandre; Saker, Kahina; Garçon, Pierre; Rivière, Jacques G; Lagier, Jean-Christophe; Gentile, Stéphanie; Rosen, Lindsey B; Shaw, Elana; Morio, Tomohiro; Tanaka, Junko; Dalmau, David; Tharaux, Pierre-Louis; Sene, Damien; Stepanian, Alain; Megarbane, Bruno; Triantafyllia, Vasiliki; Fekkar, Arnaud; Heath, James R; Franco, José Luis; Anaya, Juan-Manuel; Solé-Violán, Jordi; Imberti, Luisa; Biondi, Andrea; Bonfanti, Paolo; Castagnoli, Riccardo; Delmonte, Ottavia M; Zhang, Yu; Snow, Andrew L; Holland, Steven M; Biggs, Catherine M; Moncada-Vélez, Marcela; Arias, Andrés Augusto; Lorenzo, Lazaro; Boucherit, Soraya; Coulibaly, Boubacar; Anglicheau, Dany; Planas, Anna M; Haerynck, Filomeen; Duvlis, Sotirija; Nussbaum, Robert L; Ozcelik, Tayfun; Keles, Sevgi; Bousfiha, Ahmed A; ElBakkouri, Jalila; Ramirez-Santana, Carolina; Paul, Stéphane; Pan-Hammarström, Qiang; Hammarström, Lennart; Dupont, Annabelle; Kurolap, Alina; Metz, Christine N; Aiuti, Alessandro; Casari, Giorgio; Lampasona, Vito; Ciceri, Fabio; Barreiros, Lucila A; Dominguez-Garrido, Elena; Vidigal, Mateus; Zatz, Mayana ; Beek, Diederik van de; Sahanic, Sabina; Tancevski, Ivan; Stepanovskyy, Yurii; Boyarchuk, Oksana; Nukui, Yoko; Tsumura, Miyuki; Vidaur, Loreto; Tangye, Stuart G; Burrel, Sonia; Duffy, Darragh; Quintana-Murci, Lluis; Klocperk, Adam; Kann, Nelli Y; Shcherbina, Anna; Lau, Yu-Lung; Leung, Daniel; Coulongeat, Matthieu; Marlet, Julien; Koning, Rutger; Reyes, Luis Felipe; Chauvineau-Grenier, Angélique; Vene, Fabienne; Monneret, Guillaume; Nussenzweig, Michel C; Arrestier, Romain; Boudhabhay, Idris; Baris-Feldman, Hagit; Hagin, David; Wauters, Joost; Meyts, Isabelle; Dyer, Adam H; Kennelly, Sean P; Bourke, Nollaig M; Halwani, Rabih; Sharif-Askari, Narjes Saheb; Dorgham, Karim; Sallette, Jérome; Sedkaoui, Souad Mehlal; AlKhater, Suzan; Rigo-Bonnin, Raúl; Morandeira, Francisco; Roussel, Lucie; Vinh, Donald C; Ostrowski, Sisse Rye; Condino Neto, Antonio ; Prando, Carolina ; Bondarenko, Anastasiia; Spaan, András N; Gilardin, Laurent; Fellay, Jacques; Lyonnet, Stanislas; Bilguvar, Kaya; Lifton, Richard P; Mane, Shrikant; Anderson, Mark S; Boisson, Bertrand; Béziat, Vivien; Zhang, Shen-Ying; Andreakos, Evangelos; Hermine, Olivier; Pujol, Aurora; Peterson, Pärt; Mogensen, Trine; H Rowen, Lee; Mond, James; Debette, Stéphanie; Lamballerie, Xavier de; Duval, Xavier; Mentré, France; Zins, Marie; Soler-Palacin, Pere; Colobran, Roger; Gorochov, Guy; Solanich, Xavier; Susen, Sophie; Martinez-Picado, Javier; Raoult, Didier; Vasse, Marc; Gregersen, Peter K; Piemonti, Lorenzo; Rodríguez-Gallego, Carlos; Notarangelo, Luigi D; Su, Helen C; Kisand, Kai; Okada, Satoshi; Puel, Anne; Jouanguy, Emmanuelle; Rice, Charles M; Tiberghien, Pierre; Zhang, Qian; Cobat, Aurélie; Abel, Laurent; Casanova, Jean-Laurent
Source: Science Immunology. Unidades: IB, ICB
Subjects: COVID-19, INFECÇÕES POR CORONAVIRUS, ANTICORPOS, IMUNOLOGIA, HOMENS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BASTARD, Paul et al. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Science Immunology, v. 6, n. 62, p. 1-30, 2021Tradução . . Disponível em: https://doi.org/10.1126/sciimmunol.abl4340. Acesso em: 15 nov. 2024.
APA
Bastard, P., Gervais, A., Voyer, T. L., Rosain, J., Philippot, Q., Manry, J., et al. (2021). Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Science Immunology, 6( 62), 1-30. doi:10.1126/sciimmunol.abl4340
NLM
Bastard P, Gervais A, Voyer TL, Rosain J, Philippot Q, Manry J, Michailidis E, Hoffmann H-H, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Liis H, Migaud M, Särekannu K, Maslovskaja J, Prost N de, Tandjaoui-Lambiotte Y, Luyt C-E, Amador-Borrero B, Alexandre G, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier J-C, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux P-L, Sene D, Stepanian A, Megarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya J-M, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs CM, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Coulibaly B, Anglicheau D, Planas AM, Haerynck F, Duvlis S, Nussbaum RL, Ozcelik T, Keles S, Bousfiha AA, ElBakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarström Q, Hammarström L, Dupont A, Kurolap A, Metz CN, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros LA, Dominguez-Garrido E, Vidigal M, Zatz M, Beek D van de, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye SG, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann NY, Shcherbina A, Lau Y-L, Leung D, Coulongeat M, Marlet J, Koning R, Reyes LF, Chauvineau-Grenier A, Vene F, Monneret G, Nussenzweig MC, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer AH, Kennelly SP, Bourke NM, Halwani R, Sharif-Askari NS, Dorgham K, Sallette J, Sedkaoui SM, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh DC, Ostrowski SR, Condino Neto A, Prando C, Bondarenko A, Spaan AN, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton RP, Mane S, Anderson MS, Boisson B, Béziat V, Zhang S-Y, Andreakos E, Hermine O, Pujol A, Peterson P, Mogensen T, H Rowen L, Mond J, Debette S, Lamballerie X de, Duval X, Mentré F, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen PK, Piemonti L, Rodríguez-Gallego C, Notarangelo LD, Su HC, Kisand K, Okada S, Puel A, Jouanguy E, Rice CM, Tiberghien P, Zhang Q, Cobat A, Abel L, Casanova J-L. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths [Internet]. Science Immunology. 2021 ; 6( 62): 1-30.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1126/sciimmunol.abl4340
Vancouver
Bastard P, Gervais A, Voyer TL, Rosain J, Philippot Q, Manry J, Michailidis E, Hoffmann H-H, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Liis H, Migaud M, Särekannu K, Maslovskaja J, Prost N de, Tandjaoui-Lambiotte Y, Luyt C-E, Amador-Borrero B, Alexandre G, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier J-C, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux P-L, Sene D, Stepanian A, Megarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya J-M, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs CM, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Coulibaly B, Anglicheau D, Planas AM, Haerynck F, Duvlis S, Nussbaum RL, Ozcelik T, Keles S, Bousfiha AA, ElBakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarström Q, Hammarström L, Dupont A, Kurolap A, Metz CN, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros LA, Dominguez-Garrido E, Vidigal M, Zatz M, Beek D van de, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye SG, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann NY, Shcherbina A, Lau Y-L, Leung D, Coulongeat M, Marlet J, Koning R, Reyes LF, Chauvineau-Grenier A, Vene F, Monneret G, Nussenzweig MC, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer AH, Kennelly SP, Bourke NM, Halwani R, Sharif-Askari NS, Dorgham K, Sallette J, Sedkaoui SM, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh DC, Ostrowski SR, Condino Neto A, Prando C, Bondarenko A, Spaan AN, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton RP, Mane S, Anderson MS, Boisson B, Béziat V, Zhang S-Y, Andreakos E, Hermine O, Pujol A, Peterson P, Mogensen T, H Rowen L, Mond J, Debette S, Lamballerie X de, Duval X, Mentré F, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen PK, Piemonti L, Rodríguez-Gallego C, Notarangelo LD, Su HC, Kisand K, Okada S, Puel A, Jouanguy E, Rice CM, Tiberghien P, Zhang Q, Cobat A, Abel L, Casanova J-L. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths [Internet]. Science Immunology. 2021 ; 6( 62): 1-30.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1126/sciimmunol.abl4340
Artigo de periodico
Hematologically important mutations: X-linked chronic granulomatous disease (fourth update) (2021)
Roos, Dirk; Leeuwen, Karin van; Hsu, Amy P.; Priel, Debra Long ; Begtrup, Amber ; Brandon, Rhonda; Stasia, Marie José ; Bakri, Faris Ghalib ; Köker, Nezihe ; Köker, Mustafa Yavuz ; Madkaika, Manisha; Boer, Martin de ; Morato, Maria Bravo Garcia ; Shephard, Juan Luis Valdivieso; Roesler, Joachim ; Kanegane, Hirokazu ; Kawai, Toshinao ; Matteo, Gigliola Di ; Shahrooei, Mohammad ; Bustamante, Jacinta ; Rawat, Amit ; Vignesh, Pandiarajan ; Mortaz, Esmaeil ; Fayezi, Abbas; Cagdas, Deniz ; Tezcan, Ilhan ; Kitcharoensakkul, Maleewan ; Dinauer, Mary C. ; Meyts, Isabelle; Wolach, Baruch; Condino Neto, Antonio ; Zerbe, Christa S. ; Holland, Steven M.; Malech, Harry L. ; Gallin, John I.; Kuhns, Douglas B.
Source: Blood Cells, Molecules and Diseases. Unidade: ICB
Subjects: IMUNOLOGIA, IMUNODEFICIÊNCIA DE VARIÁVEL COMUM, MUTAÇÃO GENÉTICA, DOENÇAS SANGUÍNEAS E LINFÁTICAS, SUPERÓXIDO DISMUTASE, ATIVAÇÃO ENZIMÁTICA, IMUNOGENÉTICA, ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROOS, Dirk et al. Hematologically important mutations: X-linked chronic granulomatous disease (fourth update). Blood Cells, Molecules and Diseases, v. 90, p. 1-36, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.bcmd.2021.102587. Acesso em: 15 nov. 2024.
APA
Roos, D., Leeuwen, K. van, Hsu, A. P., Priel, D. L., Begtrup, A., Brandon, R., et al. (2021). Hematologically important mutations: X-linked chronic granulomatous disease (fourth update). Blood Cells, Molecules and Diseases, 90, 1-36. doi:10.1016/j.bcmd.2021.102587
NLM
Roos D, Leeuwen K van, Hsu AP, Priel DL, Begtrup A, Brandon R, Stasia MJ, Bakri FG, Köker N, Köker MY, Madkaika M, Boer M de, Morato MBG, Shephard JLV, Roesler J, Kanegane H, Kawai T, Matteo GD, Shahrooei M, Bustamante J, Rawat A, Vignesh P, Mortaz E, Fayezi A, Cagdas D, Tezcan I, Kitcharoensakkul M, Dinauer MC, Meyts I, Wolach B, Condino Neto A, Zerbe CS, Holland SM, Malech HL, Gallin JI, Kuhns DB. Hematologically important mutations: X-linked chronic granulomatous disease (fourth update) [Internet]. Blood Cells, Molecules and Diseases. 2021 ; 90 1-36.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.bcmd.2021.102587
Vancouver
Roos D, Leeuwen K van, Hsu AP, Priel DL, Begtrup A, Brandon R, Stasia MJ, Bakri FG, Köker N, Köker MY, Madkaika M, Boer M de, Morato MBG, Shephard JLV, Roesler J, Kanegane H, Kawai T, Matteo GD, Shahrooei M, Bustamante J, Rawat A, Vignesh P, Mortaz E, Fayezi A, Cagdas D, Tezcan I, Kitcharoensakkul M, Dinauer MC, Meyts I, Wolach B, Condino Neto A, Zerbe CS, Holland SM, Malech HL, Gallin JI, Kuhns DB. Hematologically important mutations: X-linked chronic granulomatous disease (fourth update) [Internet]. Blood Cells, Molecules and Diseases. 2021 ; 90 1-36.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.bcmd.2021.102587
Artigo de periodico
The global response to the COVID-19 pandemic: how have immunology societies contributed ? (2020)
Osier, Faith; Ting, Jenny P. Y.; Fraser, John; Lambrecht, Bart N.; Romano, Marta; Gazzinelli, Ricardo Tostes ; Bortoluci, Karina Ramalho ; Zamboni, Dario Simões ; Akbar, Arne N.; Evans, Jennie; Brown, Doug E.; Patel, Kamala D.; Wu, Yuzhang; Perez, Ana Beatriz Alvarez; Pérez, Oliver; Kamradt, Thomas; Falk, Christine; Barda-Saad, Mira; Ariel, Amiram; Santoni, Angela; Annunziato, Francesco; Cassatella, Marco A.; Kiyono, Hiroshi; Chereshnev, Valeriy; Dieye, Alioune; Mbow, Moustapha; Mbengue, Babacar; Niang, Maguette D. S.; Suchard, Melinda
Source: Nature Reviews Immunology. Unidade: FMRP
Subjects: ANTIVIRAIS, USOS TERAPÊUTICOS, IMUNOLOGIA, COVID-19, INFECÇÕES POR CORONAVIRUS, PREVENÇÃO DE DOENÇAS, EPIDEMIOLOGIA, VACINAS, EDUCAÇÃO DO PACIENTE, EQUIPAMENTO DE PROTEÇÃO INDIVIDUAL, PNEUMONIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OSIER, Faith et al. The global response to the COVID-19 pandemic: how have immunology societies contributed ?. Nature Reviews Immunology, v. 20, p. 594-602, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41577-020-00428-4. Acesso em: 15 nov. 2024.
APA
Osier, F., Ting, J. P. Y., Fraser, J., Lambrecht, B. N., Romano, M., Gazzinelli, R. T., et al. (2020). The global response to the COVID-19 pandemic: how have immunology societies contributed ? Nature Reviews Immunology, 20, 594-602. doi:10.1038/s41577-020-00428-4
NLM
Osier F, Ting JPY, Fraser J, Lambrecht BN, Romano M, Gazzinelli RT, Bortoluci KR, Zamboni DS, Akbar AN, Evans J, Brown DE, Patel KD, Wu Y, Perez ABA, Pérez O, Kamradt T, Falk C, Barda-Saad M, Ariel A, Santoni A, Annunziato F, Cassatella MA, Kiyono H, Chereshnev V, Dieye A, Mbow M, Mbengue B, Niang MDS, Suchard M. The global response to the COVID-19 pandemic: how have immunology societies contributed ? [Internet]. Nature Reviews Immunology. 2020 ; 20 594-602.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1038/s41577-020-00428-4
Vancouver
Osier F, Ting JPY, Fraser J, Lambrecht BN, Romano M, Gazzinelli RT, Bortoluci KR, Zamboni DS, Akbar AN, Evans J, Brown DE, Patel KD, Wu Y, Perez ABA, Pérez O, Kamradt T, Falk C, Barda-Saad M, Ariel A, Santoni A, Annunziato F, Cassatella MA, Kiyono H, Chereshnev V, Dieye A, Mbow M, Mbengue B, Niang MDS, Suchard M. The global response to the COVID-19 pandemic: how have immunology societies contributed ? [Internet]. Nature Reviews Immunology. 2020 ; 20 594-602.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1038/s41577-020-00428-4
Artigo de periodico
Characterization of Greater Middle Eastern genetic variation for enhanced disease gene discovery (2016)
Scott, Eric M.; Halees, A.; Itan, Y.; Spencer, E. G.; He,Y.; Azab, M. A.; Gabriel, S. B.; Belkadi, A.; Boisson, B.; Abel, L.; Clark, A. G.; Consortium, Greater Middle East Variome; Alkuraya, F. S.; Casanova, J. L.; Gleeson, J. G.; Rahim, S. A.; Abdel-Hadi, S.; Abdel-Salam, G.; Abdel-Salam, E.; Abdou, M.; Abhytankar, A.; Adimi, P.; Ahmad, J.; Akcakus, M.; Aksu, G.; Hajjar, S. A.; Juamaah, S. A.; Muhsen, S. A.; Sannaa, N. A.; Tameni, S. A.; Al-Aama, J.; Al-Allawi, N.; Al-Baradie, R.; Al-Gazali, L.; Al-Hashem, A.; Al-Herz, W.; Al-Jeaid, D.; Al-Tawari, A.; Alangari, A.; Alcais, A.; AlFawaz, T.; Alsum, Z.; Ammar-Khodja, A.; Amouian, S.; Ammar-Khodja, A.; Arikan, C.; Aryani, O.; Aslanger, A.; Aydogmus, C.; Aytekin, C.; Azam, M.; Bansagi, B.; Barbouche, M. R.; Bastaki, L.; Ben-Omran, T.; Bindu, P. S.; Blancas, L.; Boisson-Dupuis, S.; Bonnet, D.; Stambouli, O. B.; Bousfiha, A.; Boussafara, L.; Boutros, J.; Bustamante, J.; Caksen, H.; Camcioglu, Y.; Catherinot, E.; Celik, F. C.; Ciancanelli, M.; Cipe, F. E.; Clark, G.; Cobat, A.; Comu, S.; Condie, A.; Condino-Neto, A.; Desai, M.; Dobyns, W.; Dogu, F.; Domaia, M.; Egritas, O.; Azbaoui, S. E.; Baghdadi, J. E.; Ruby, M. E.; El-Harouni, A.; Elfeky,R. A.; Elghazali, G.; Faqeih, E.; Fenerci, E.; Fieschi, C.; Funda, C.; Gamal, I.; Gelik, U.; Genel, F.; Gezdirici, A.; Girisha, K. M.; Goldstein, A.; Grattan-Smith, P.; Gupta, N.; Hahn, J.; Hatipoglu, N.; Hennekam, R.; Houshmand, M.; Ichai, P.; Ikinciogullari, A.; Ismail, S.; Jalas, C.; Jouanguy, E.; Kabra, M.; Kalkan, G.; Kara, M.; Karaca, N.; Karaer, K.; Kariminejad, A.; Kayserili, H.; Keser-Emiroglu, M.; Kilic, S. S.; Kissani, N.; Kokron, C.; Koul, R.; Kutukculer, N.; Lanternier, F.; Mahdaviani, A.; Mahlaoui, N.; Mansour, L.; Mansouri, D.; Margari, L.; Valente, E. M.; Marzouki, N.; Masri, A.; Megahed, A.; Megahed, H.; Mekki, N.; Mesdaghi, M.; Mikati, M.; Mojahedi, F.; Mulley, J.; Nampoothiri, S.; Navarrete, C.; Omar, T.; Oraby, A.; Pandaluz, A.; Parvaneh, N.; Patiroglu, T.; Koc, Z. P.; Pellier, I.; Picard, C.; Puel, A.; Raas-Rothschild, A.; Rajab, A.; Raoult, D.; Reisli, I.; Rezaei, N.; Sabri, A.; Sahin, Y.; Saleem, L.; Salem, F.; AlSediq, N. S.; Sanal, O.; Sanger, T.; Shakankiry, H.; Shang, L.; Shehata, N.; Shembesh, N.; Shkalim, V.; Softah, A.; Sogaty, S.; Soliman, N.; Sonmez Aunaci, F.; Sztriha, L.; Taibi-Berrah, L.; Temtamy, S.; Tonekaboni, H.; Trauner, D.; Tuysuz, B.; Varan, A.; Vogt, G.; Walsh, C.; Woods, G.; Yesil, G.; Yildiran, A.; Yildiz, B.; Yuksel, A.; Zaki, M.; Zhang, S. Y.
Source: Nature Genetics. Unidade: ICB
Subjects: VARIAÇÃO GENÉTICA, GENÉTICA, GENÉTICA DE POPULAÇÕES, IMUNOLOGIA, ALELOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCOTT, Eric M. et al. Characterization of Greater Middle Eastern genetic variation for enhanced disease gene discovery. Nature Genetics, v. 48, n. 9, p. 1071-1076, 2016Tradução . . Disponível em: https://doi.org/10.1038/ng.3592. Acesso em: 15 nov. 2024.
APA
Scott, E. M., Halees, A., Itan, Y., Spencer, E. G., He, Y., Azab, M. A., et al. (2016). Characterization of Greater Middle Eastern genetic variation for enhanced disease gene discovery. Nature Genetics, 48( 9), 1071-1076. doi:10.1038/ng.3592
NLM
Scott EM, Halees A, Itan Y, Spencer EG, He Y, Azab MA, Gabriel SB, Belkadi A, Boisson B, Abel L, Clark AG, Consortium GMEV, Alkuraya FS, Casanova JL, Gleeson JG, Rahim SA, Abdel-Hadi S, Abdel-Salam G, Abdel-Salam E, Abdou M, Abhytankar A, Adimi P, Ahmad J, Akcakus M, Aksu G, Hajjar SA, Juamaah SA, Muhsen SA, Sannaa NA, Tameni SA, Al-Aama J, Al-Allawi N, Al-Baradie R, Al-Gazali L, Al-Hashem A, Al-Herz W, Al-Jeaid D, Al-Tawari A, Alangari A, Alcais A, AlFawaz T, Alsum Z, Ammar-Khodja A, Amouian S, Ammar-Khodja A, Arikan C, Aryani O, Aslanger A, Aydogmus C, Aytekin C, Azam M, Bansagi B, Barbouche MR, Bastaki L, Ben-Omran T, Bindu PS, Blancas L, Boisson-Dupuis S, Bonnet D, Stambouli OB, Bousfiha A, Boussafara L, Boutros J, Bustamante J, Caksen H, Camcioglu Y, Catherinot E, Celik FC, Ciancanelli M, Cipe FE, Clark G, Cobat A, Comu S, Condie A, Condino-Neto A, Desai M, Dobyns W, Dogu F, Domaia M, Egritas O, Azbaoui SE, Baghdadi JE, Ruby ME, El-Harouni A, Elfeky RA, Elghazali G, Faqeih E, Fenerci E, Fieschi C, Funda C, Gamal I, Gelik U, Genel F, Gezdirici A, Girisha KM, Goldstein A, Grattan-Smith P, Gupta N, Hahn J, Hatipoglu N, Hennekam R, Houshmand M, Ichai P, Ikinciogullari A, Ismail S, Jalas C, Jouanguy E, Kabra M, Kalkan G, Kara M, Karaca N, Karaer K, Kariminejad A, Kayserili H, Keser-Emiroglu M, Kilic SS, Kissani N, Kokron C, Koul R, Kutukculer N, Lanternier F, Mahdaviani A, Mahlaoui N, Mansour L, Mansouri D, Margari L, Valente EM, Marzouki N, Masri A, Megahed A, Megahed H, Mekki N, Mesdaghi M, Mikati M, Mojahedi F, Mulley J, Nampoothiri S, Navarrete C, Omar T, Oraby A, Pandaluz A, Parvaneh N, Patiroglu T, Koc ZP, Pellier I, Picard C, Puel A, Raas-Rothschild A, Rajab A, Raoult D, Reisli I, Rezaei N, Sabri A, Sahin Y, Saleem L, Salem F, AlSediq NS, Sanal O, Sanger T, Shakankiry H, Shang L, Shehata N, Shembesh N, Shkalim V, Softah A, Sogaty S, Soliman N, Sonmez Aunaci F, Sztriha L, Taibi-Berrah L, Temtamy S, Tonekaboni H, Trauner D, Tuysuz B, Varan A, Vogt G, Walsh C, Woods G, Yesil G, Yildiran A, Yildiz B, Yuksel A, Zaki M, Zhang SY. Characterization of Greater Middle Eastern genetic variation for enhanced disease gene discovery [Internet]. Nature Genetics. 2016 ; 48( 9): 1071-1076.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1038/ng.3592
Vancouver
Scott EM, Halees A, Itan Y, Spencer EG, He Y, Azab MA, Gabriel SB, Belkadi A, Boisson B, Abel L, Clark AG, Consortium GMEV, Alkuraya FS, Casanova JL, Gleeson JG, Rahim SA, Abdel-Hadi S, Abdel-Salam G, Abdel-Salam E, Abdou M, Abhytankar A, Adimi P, Ahmad J, Akcakus M, Aksu G, Hajjar SA, Juamaah SA, Muhsen SA, Sannaa NA, Tameni SA, Al-Aama J, Al-Allawi N, Al-Baradie R, Al-Gazali L, Al-Hashem A, Al-Herz W, Al-Jeaid D, Al-Tawari A, Alangari A, Alcais A, AlFawaz T, Alsum Z, Ammar-Khodja A, Amouian S, Ammar-Khodja A, Arikan C, Aryani O, Aslanger A, Aydogmus C, Aytekin C, Azam M, Bansagi B, Barbouche MR, Bastaki L, Ben-Omran T, Bindu PS, Blancas L, Boisson-Dupuis S, Bonnet D, Stambouli OB, Bousfiha A, Boussafara L, Boutros J, Bustamante J, Caksen H, Camcioglu Y, Catherinot E, Celik FC, Ciancanelli M, Cipe FE, Clark G, Cobat A, Comu S, Condie A, Condino-Neto A, Desai M, Dobyns W, Dogu F, Domaia M, Egritas O, Azbaoui SE, Baghdadi JE, Ruby ME, El-Harouni A, Elfeky RA, Elghazali G, Faqeih E, Fenerci E, Fieschi C, Funda C, Gamal I, Gelik U, Genel F, Gezdirici A, Girisha KM, Goldstein A, Grattan-Smith P, Gupta N, Hahn J, Hatipoglu N, Hennekam R, Houshmand M, Ichai P, Ikinciogullari A, Ismail S, Jalas C, Jouanguy E, Kabra M, Kalkan G, Kara M, Karaca N, Karaer K, Kariminejad A, Kayserili H, Keser-Emiroglu M, Kilic SS, Kissani N, Kokron C, Koul R, Kutukculer N, Lanternier F, Mahdaviani A, Mahlaoui N, Mansour L, Mansouri D, Margari L, Valente EM, Marzouki N, Masri A, Megahed A, Megahed H, Mekki N, Mesdaghi M, Mikati M, Mojahedi F, Mulley J, Nampoothiri S, Navarrete C, Omar T, Oraby A, Pandaluz A, Parvaneh N, Patiroglu T, Koc ZP, Pellier I, Picard C, Puel A, Raas-Rothschild A, Rajab A, Raoult D, Reisli I, Rezaei N, Sabri A, Sahin Y, Saleem L, Salem F, AlSediq NS, Sanal O, Sanger T, Shakankiry H, Shang L, Shehata N, Shembesh N, Shkalim V, Softah A, Sogaty S, Soliman N, Sonmez Aunaci F, Sztriha L, Taibi-Berrah L, Temtamy S, Tonekaboni H, Trauner D, Tuysuz B, Varan A, Vogt G, Walsh C, Woods G, Yesil G, Yildiran A, Yildiz B, Yuksel A, Zaki M, Zhang SY. Characterization of Greater Middle Eastern genetic variation for enhanced disease gene discovery [Internet]. Nature Genetics. 2016 ; 48( 9): 1071-1076.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1038/ng.3592

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Source title

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration